Guardant Health
GH
#1716
Rank
โ‚น1.105 T
Marketcap
โ‚น8,431
Share price
-0.63%
Change (1 day)
131.77%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -โ‚น289.89

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น308.10. In 2024 the company made an earnings per share (EPS) of -โ‚น331.37 an increase over its 2023 EPS that were of -โ‚น398.39.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น289.89-12.52%
2024-โ‚น331.37-16.82%
2023-โ‚น398.39-33.13%
2022-โ‚น595.7260%
2021-โ‚น372.3255.04%
2020-โ‚น240.15207.14%
2019-โ‚น78.19-19.81%
2018-โ‚น97.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น258.49-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น199.19-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA